Japanese-developed anti-influenza drug, Favipiravir, has been endorsed by China’s health leadership as an anti-viral drug for Coronavirus.
This was confirmed by China’s director of the National Center for Biotechnology Development, Zhang Xinmin.
According to Zhang Xinmin, the Avigan (Favipiravir) drug was found to be effective in two clinical trials completed in Wuhan and Shenzhen involving 320 patients.
During a conference in Beijing on Tuesday, Zhang said the medicine worked for coronavirus-related symptoms including pneumonia and had no obvious side effects.
“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters.
Patients who were given the medicine in Shenzhen turned negative for the virus after four days of therapy, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
The director said he formally recommended the use of this medicine as a way to treat the COVID-19 disease, which is caused by the SARS-CoV-2 virus.
According to Zhang, a Chinese pharmaceutical company has been approved by the National Medical Products Administration to mass-produce the medication and ensure a stable supply.
You may be interested
Osun Free Train Service: Beneficiaries Laud Initiative, Say It’s Great ReliefWebby - May 13, 2021
…as 650 Eid-el-Fitr holiday-makers visit Osun for sallah The beneficiaries of Osun Free Train Service on Wednesday described the government’s…
Nigerian Army Lied, Man Arrested Is Not ESN Commander – Nnamdi KanuWebby - May 13, 2021
IPOB leader, Nnamdi Kanu Claims by the Nigerian army that it arrested Eastern Security Network, ESN, Deputy Commander has been…
Busted! EFCC Nabs Fake Officials Extorting Lagos ResidentsWebby - May 13, 2021
Otigba, who took to his Twitter handle on Thursday, said the officials were caught with fake EFCC identity cards and…